Streetbeat News

Legal

AAPL

A new patent granted to Apple, with Jony Ive as an inventor, explores using an external display on a head-mounted device, potentially the Vision Pro, to show various images, including the wearer's eyes or symbols like a 'DO NOT DISTURB' sign. While the patent includes playful ideas, such as replacing eyes with Zoom icons, it's uncertain if these features will be included in the final product. Apple's Vision Pro and its EyeSight display are nearing launch, but their practicality and effectiveness remain to be seen as they have not been demoed to the press.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 11:35 pm

DIS

ETH-USD

The 1928 version of Mickey Mouse from 'Steamboat Willie' has entered the public domain, leading to new interpretations, including a horror film 'Mickey's Mouse Trap.' Disney (NYSE:DIS) no longer holds copyright over this version of the character. The film is not affiliated with Disney and has no release date yet. A survival horror game 'Infestation 88' is also in development. An NFT collection based on Steamboat Willie sold out quickly and has seen significant price appreciation.

Portfolio Pulse from Chris Katje

January 02, 2024 | 9:47 pm

PSHZF

Harvard University President Claudine Gay resigned amid allegations of plagiarism and controversy over her Congressional testimony. Bill Ackman, hedge fund manager and Harvard alum, criticized the university's handling of the situation, stating it has stained Harvard's reputation. Ackman's comments were made before Gay's resignation was announced.

Portfolio Pulse from Anthony Noto

January 02, 2024 | 7:54 pm

JNJ

A federal judge in New Jersey has allowed Johnson & Johnson (NYSE:JNJ) shareholders to proceed with a class action lawsuit over alleged concealment of asbestos contamination in its talc products. The class period spans from February 22, 2013, to December 13, 2018. The lawsuit could enhance shareholders' ability to recover damages. Despite the litigation, JNJ shares rose 1.51% to $159.10.

Portfolio Pulse from Vandana Singh

January 02, 2024 | 7:01 pm

Juul Labs Inc. board members Nick Pritzker and Riaz Valani are accused of self-interest in a bailout that preserved their equity investments. Investors have sued, alleging the 2022 bailout favored insiders. Altria Group Inc (NYSE:MO), which invested $12.8 billion in Juul in 2018, has seen its stake diluted after a 2023 funding round. Juul, facing lawsuits and regulatory issues, avoided bankruptcy and is seeking to raise an additional $330 million in 2024.

Portfolio Pulse from Vandana Singh

January 02, 2024 | 6:57 pm

DATS

DatChat has been granted a U.S. patent (No. 11861030) for its technology platform that enables secure group-based access to digital assets. This patent could potentially enhance the company's intellectual property portfolio and provide a competitive edge in the market for secure communication and digital asset management solutions.

Portfolio Pulse from Charles Gross

January 02, 2024 | 6:51 pm

GDRX

LBPH

MRNA

MSTR

RIVN

VYGR

Longboard Pharmaceuticals, Inc. (LBPH) shares soared by approximately 200% after announcing positive topline data from their PACIFIC Phase 1b/2a study of bexicaserin (LP352) for seizures associated with Developmental and Epileptic Encephalopathies (DEEs). Other stocks experienced significant movement in Tuesday's mid-day session, with various companies seeing substantial gains or losses.

Portfolio Pulse from Avi Kapoor

January 02, 2024 | 6:35 pm

AVXL

CORT

LBPH

LMDX

RIVN

SNES

VYGR

U.S. stocks traded mixed with the Dow Jones gaining and NASDAQ falling. Energy shares rose while information technology shares fell. Rivian Automotive reported lower-than-expected Q4 vehicle deliveries. Longboard Pharmaceuticals surged on positive study data, while Anavex Life Sciences plunged after an update on its Rett Syndrome program. LumiraDx fell after agreeing to sell its technology platform to Roche, and Corcept Therapeutics dropped due to a court decision favoring Teva Pharmaceuticals. Oil prices decreased, and gold prices saw a slight increase.

Portfolio Pulse from Avi Kapoor

January 02, 2024 | 5:15 pm

CORT

MDXG

RIVN

Rivian Automotive (RIVN) reported lower-than-expected delivery figures for Q4 2023, causing its shares to drop 9.1%. Other stocks also moved lower, including Corcept Therapeutics (CORT) after a court decision, Anavex Life Sciences (AVXL) following a program update, and MiMedx Group (MDXG) after receiving an FDA warning letter. Several companies faced downgrades or negative financial updates, contributing to declines in their stock prices.

Portfolio Pulse from Avi Kapoor

January 02, 2024 | 4:47 pm

ENVB

Enveric Biosciences Canada has been granted U.S. Patent #11858895, which covers aminated psilocybin derivatives and methods of their use. This patent could potentially strengthen the company's intellectual property portfolio and provide a competitive edge in the field of psychedelic compounds for therapeutic use.

Portfolio Pulse from Charles Gross

January 02, 2024 | 4:44 pm